Latest news

Skip to main content ( press enter )

404 Not Found: {"_index":"foundation_elasticsearch","_id":"petermac_elasticsearch_a-whole-new-frontier-long-read-sequencing-arrives-at-peter-mac-hr","found":false}

@Follow us on Instagram (@SupportPeterMac)

Someone special is coming to Peter Mac. Beyond the rivalry. Beyond the game. 👀 Stay tuned.

For more than 30 years, two legendary rivals have come together for something bigger than footy. The Peter Mac Cup is the longest-running charity match in VFL and AFL history, played between Collingwood and Carlton to raise vital funds for cancer research and care at Peter MacCallum Cancer Centre. What started as a single match has become one of the Peter MacCallum Cancer Foundation’s largest annual fundraising events, uniting footy fans behind a powerful cause. In 2026, the tradition continues. Circle it, lock it in and don’t miss it. The Peter Mac Cup returns on April 16. Carlton Blues vs Collingwood Magpies. April 16, 7.30pm at the MCG. Legendary rivals on the field. United against cancer off the field. Will you be there? 💜🖤💙

Bringing together the ‘best of both worlds’ in prostate cancer treatment could significantly improve the treatment experience for many patients. Prostate cancer is the most common cancer affecting males, and the number of new cases globally is expected to rise by over 100% from 2020 to 2040. Developing effective and efficient new ways to treat prostate cancer is crucial. This is exactly what A/Prof Sarat Chander (first slide) and Dr David Chang (second slide) hope to achieve with the support of a 2025 Peter Mac Foundation Grant. Currently, high dose rate (HDR) brachytherapy and stereotactic ablative body radiotherapy (SABR) are some of the most convenient options available for localised prostate cancer, the stage when most prostate cancer cases are caught. Both options have benefits and drawbacks: HDR brachytherapy involves fewer sessions but is more invasive, while SABR is less invasive but requires more visits. Their trial is investigating a hybrid approach that streamlines the treatment process, making it both less invasive and time-consuming. This approach would make treatment more convenient and more accessible for regional and rural patients. It would advance outcomes, reduce costs for patients, and improve the quality of life for patients with early-stage prostate cancer. Because of your generosity, researchers like A/Prof Chander and Dr Chang can explore new and improved ways of treating cancer. Thank you for helping to create a better future for all people affected by cancer.

Cam loved the feeling of being unstoppable – until one day, he wasn’t. It began as pain on the side of his face. And headaches. At first, doctors diagnosed a sinus infection, then cluster headaches. But the pain worsened, until Cam was in agony. It was rhabdomyosarcoma: a rare and aggressive tumour near Cam’s brain. Within 48 hours, Cam was at Peter Mac beginning intensive treatment. At just 18, when most young people are dreaming about their future, he was fighting to have one. His mum, Judy, felt helpless as treatment took its toll. 💬 “The first rounds of chemo were the strongest and resulted in trips to the ED and subsequent hospital stays. It was not only physically taxing, but also emotionally depleting on Cam, as well as his dad, brother and me... it was the toughest year of my life” – Judy, Cam’s mum. Cancer treatment still looks like this for too many families. But at Peter Mac, researchers are working to unlock new treatments for all cancers. So people like Cam can survive cancer and get back to the lives they love. Read more: foundation.petermac.org/cam

Income protection, check. Superannuation, check. Finally returned that regrettable late-night online shopping impulse purchase, check. But your Will? If it’s still sitting on the life admin list, we’ve just made it a whole lot easier. Peter Mac has partnered with Safewill to offer our supporters the chance to create a free, legally valid Will during Charity Wills Week (16–30 March). It only takes around 20 minutes online and gives you peace of mind knowing your wishes are clear and your loved ones are protected. Many people also choose this moment to reflect on the legacy they’d like to leave. While there’s absolutely no obligation, you can choose to include a gift to Peter Mac in your Will to support life-saving cancer research and care into the future. ✔ Simple online process ✔ Legally binding ✔ Reviewed by an Australian solicitor ✔ FREE Tick it off your life admin list before 30 March by heading to the link in bio.

This cancer type is rare, which makes it hard to study. But researchers at Peter Mac know how to tackle it. 🤝 For sarcoma and other rare cancers, collaboration is key. When cancers are rare, there are too few patients in one place. This means few clinical trials to learn from. Not enough evidence to guide the best way forward. Professor David Gyorki is passionate about changing this. Prof Gyorki connects cancer centres around the world to improve treatments for sarcomas. The researchers share knowledge, compare results, and build the evidence. 💬 “Because it's a group of rare cancers, we have this group of global sarcoma experts all with a commitment to improving outcomes. We're dedicated to learning from each other,” says Prof Gyorki. Every study, every trial, every shared dataset adds to our understanding of how to stop cancer sooner. Cancer research is a worldwide effort. Through Peter Mac, you can help. Read more: foundation.petermac.org/profdavidgyorki